Skip to main content

Table 2 Patients’ characteristics according to CD4+ and CD8+ T lymphopenia

From: Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

 

Overall population (N = 169)

Absolute TL CD4 count ≤ 500 (N = 48)

Absolute TL CD4 count > 500 (N = 121)

P

Absolute TL CD8 count ≤ 224 (N = 50)

 

Absolute TL CD8 count > 224 (N = 119)

 

P

 

N

 

N

 

N

  

N

 

N

 

Clinical characteristics

Age — years

64.5 (57.5 - + 70.5)

169

65.5 (60.5–76.6)

48

63.7 (56.9–69.7)

121

0.0532

65.7 (61.9–72.1)

50

63.3 (56.8–70.5)

119

0.0925

Patient male sex

110 (65%)

169

33 (69%)

48

77 (64%)

121

0.5938

35 (70%)

50

75 (63%)

119

0.3853

Smoking status

 

169

 

48

 

121

  

50

 

119

 

 Current or former smoker

147 (87%)

 

42 (87%)

 

105 (87%)

 

1.000

45 (90%)

 

102 (85.7%)

  

 Never smoker

22 (13%)

 

6 (13%)

 

16 (13%)

 

5 (10%)

 

17 (14.3%)

 

0.4498

Performance status OMS

 

167

 

47

 

120

  

48

 

119

 

 0–1

134 (80%)

 

33 (70%)

 

101 (84%)

 

0.0417

39 (81.3%)

 

95 (79.3%)

  

 2

33 (20%)

 

14 (30%)

 

19 (16%)

 

9 (18.2%)

 

24 (20.2%)

 

0.8350

Pathological characteristics

Histologic subtype

 

141

 

46

 

95

  

44

 

97

 

 Adenocarcinoma

87 (62%)

 

26 (57%)

 

61 (64%)

 

0.0813

29 (65.9%)

 

58 (59.8%)

  

 Squamous cell carcinoma

37 (26%)

 

17 (37%)

 

20 (21%)

 

11 (25%)

 

26 (26.8%)

  

 other

17 (12%)

 

3 (6%)

 

14 (15%)

 

4 (9.1%)

 

13 (13.4%)

 

0.7091

KRAS mutation

19 (26%)

74

5 (20%)

25

14 (29%)

49

0.5758

4 (15.4%)

26

15 (31.3%)

48

0.1358

EGFR mutation

11 (14%)

79

4 (15%)

26

7 (13%))

53

1.0000

4 (14.3%)

28

7 (13.7%)

51

1.000

Stage

 

169

 

48

20 (21%)

121

  

50

 

119

 

 Local/loco-regional

86 (51%)

 

21 (44%)

 

65 (54%)

 

0.2424

27 (54%)

 

59 (49.6%)

 

0.5998

 Advanced

83 (49%)

 

27 (56%)

 

56 (46%)

 

23 (46%)

 

60 (50.4%)

Â